MARK TSAI: Open Payments
NPI 1225033111 · PARAMOUNT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 57 payments from 11 companies in 2025. Trend: 2023 $1,411 · 2024 $1,842 · 2025 $2,095
Food & beverage: $2,095
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $537 |
| AstraZeneca Pharmaceuticals LP | 5 | $367 |
| Amgen Inc. | 12 | $318 |
| Lilly USA, LLC | 8 | $200 |
| Gilead Sciences, Inc. | 6 | $192 |
| Exact Sciences Corporation | 2 | $138 |
| Inspire Medical Systems, Inc. | 1 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| Novo Nordisk Inc | 3 | $72 |
| ABBVIE INC. | 2 | $49 |
Products named: REZDIFFRA, FARXIGA, REPATHA, KRYSTEXXA, BREZTRI, INSPIRE, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across CA — which companies pay providers there.
